Stocks To Buy Now Blog

All posts by Christopher

Giggles N’ Hugs, Inc. (GIGL) Encouraging Repeat Customers with Intriguing Membership Program

GIGL

When combining a traditional restaurant concept with the excitement of innovative entertainment options, membership programs and value cards can make a huge difference to a company’s bottom line. To illustrate this fact, one needs look no further than Dave and Buster’s Entertainment, Inc. (NASDAQ: PLAY), the growing force behind one of the most popular dining and entertainment chains for adults and families in North America. Since opening its first location in 1982, Dave & Buster’s has grown into a national phenomenon, operating 73 locations across the United States.

Today, the Dave & Buster’s brand is synonymous with good times, and that’s because of PLAY’s ability to evolve and adapt with changing consumer demand. One of the best examples of this evolution was the introduction of PLAY’s pioneering rechargeable Power Cards. When diners want to enjoy a few arcade games at their local Dave & Buster’s, fumbling with cash or coins never gets in the way of the fun thanks to these reloadable cards. While this model offers convenience for customers, it also promotes repeat visits by storing deposited funds for use on the next visit.

Although Dave & Buster’s is one of the most recognizable brands in the food and entertainment space to implement a rewards card-based customer retention strategy, it’s far from the only restaurant chain capitalizing on this proven tool. Giggles N’ Hugs, Inc. (OTCQB: GIGL) – the first and only known restaurant brand that brings together high-end, organic food with active, cutting-edge play and entertainment for children – has implemented a similar model to build upon the early successes of its three locations in Greater Los Angeles.

The GIGL membership program allows parents to minimize the cost of visits to Giggles N’ Hugs locations by purchasing unlimited play passes for one-, three- or six-month intervals. For less than the cost of four visits, GIGL members can enjoy unlimited visits for a full month, and additional savings are offered for families with multiple children. To sweeten the deal, the company often offers additional benefits – including discounts on food and beverage purchases and birthday parties. This program encourages repeat visits for the company’s customers and, as a result, bolstered financial growth for GIGL.

Just in time for the holiday season, GIGL also offers gift cards, which can be purchased directly through the company’s website. By offering membership specials and other promotional deals, GIGL is in a favorable position to maintain its status as Los Angeles’s #1 Family Restaurant. As the company seeks to expand upon its national footprint in the coming months, look for this proven branding strategy to play a key role in GIGL’s efforts to promote sustainable growth.

For more information, please visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

OurPet’s Company (OPCO) Targeting Significant Market Growth with Investment in Distribution and Marketing Infrastructure

Anatole France, who won the Nobel Prize for Literature in 1921, famously said, “Until one has loved an animal, a part of one’s soul remains unawakened.” We know how true that is, because we do love our animals. In Pet Population & Ownership Trends (November 2014), the market research company Packaged Facts reported that about 55% of the U.S. adult population (133 million people) has at least one pet. Dogs are our favorites. There are 45 million households with man’s best friend. Another 30 million or so of us own (or are owned by) a cat. Then, there are the almost 7 million who love fish and the 4 million who fly with the birds and even some 3.5 million who own a reptile.

The American Pet Products Association (APPA) estimates that U.S. pet industry spending will be about $60.59 billion this year. Most of this, some $23.04 billion, will go toward food, of course. The vet will get about one-quarter of that, or $15.73 billion. Another $14.39 billion will go for over-the-counter medicines and supplies. Keeping our pets in a safe place while we go away and grooming services will cost us another $5.24 billion, and getting new pets will involve an investment of $2.19 billion. The industry has grown at an annually compounded rate of 4.6% over the past five years, from $48.35 billion at the end of 2010 to the 2015 estimate of $60.59 billion.

There are a number of factors underpinning this market expansion. First, the industry has been successful in emphasizing the bond we have with our pets. The typical American regards his dog or cat as a member of the family. This has driven sales of top-end products. Second, many upper-income households spend heavily on pet care products, such as toys and other devices that cater to their pet’s mental well-being. Third, the participation of upper-income households in the market has spurred the development of the pet specialty channel, which caters to more esoteric products. Finally, the recognition that pets, like us, need specialized health care has given rise to a burgeoning market.

Despite favorable market conditions, opportunities to invest in this lucrative industry are limited. Most companies in pet care and supplies, save a few, are private. Apart from the big dogs like PetSmart, Inc (NASDAQ: PETM) and Central Garden & Pet (NASDAQ: CENT), there’s very little else on the big exchanges.

There is, however, an oasis in this desert of investment opportunities. OurPet’s Company (OTCQX: OPCO) has been growing much faster than the industry. Since 2010, it has recorded a compound annual growth rate of about 6%. In 2011, it initiated a two-pronged branding strategy. The OurPets brand is aimed at the pet aficionado, while the Pet Zone brand is designed for the mass market. This strategy has, undoubtedly, paid off.

The management team is ambitious. In a recent interview, they confessed their objective to double the size of the company. As part of that initiative, they are investing heavily in distribution and marketing infrastructure. Also, they plan to make the waste and odor category a more significant part of OPCO’s business. Spearheading this thrust is the Smart Scoop product line. OPCO’s strategic business plan calls for annual year over year sales growth of 20% with targeted net income as a percentage of sales in the 10% – 12% range. Looks like the guys at OPCO plan to make investors purr.

For more information, visit the company’s website at www.ourpets.com

Let us hear your thoughts: OurPet’s Co. Message Board

International Stem Cell Corp. (ISCO) Edges Ever Closer to First Real Therapeutic Solution for Halting & Even Reversing Parkinson’s

With the recent announcement from Australia’s version of the FDA, the Therapeutic Goods Administration, that pluripotent stem cell manufacturing innovator International Stem Cell Corp. (OTCQB: ISCO) has been cleared to start Phase I/IIa dose escalation clinical trials focused on the safety and efficacy of its human parthenogenetic neural stem cells (ISC-hpNSCs), the company has taken another major step toward a real therapeutic solution to Parkinson’s disease. An incurable condition that primarily affects the planet’s growing elderly population, Parkinson’s currently afflicts well over 10 million people worldwide and represents a therapeutics market somewhere in the neighborhood of $2.6 billion.

However, while the sale of extant therapeutics will continue to be dominated by mere dopamine agonists and an increasing use of MAO-B inhibitors (historically used to treat depression), such treatments are palliative at best, and sales will be substantially impacted by the rapid proliferation of generics. Even the newer agents coming down the industry’s pipeline through to 2020, such as a reformulated levodopa from Impax Laboratories (NASDAQ: IPXL) and GlaxoSmithKline (NYSE: GSK), or the MAO-B inhibitor safinamide being developed by Merck (NYSE: MRK), Newron (OTC: NWPHF) and EMD Serono, will be forced to compete with generics.

ISCO, on the other hand, has the inside track in this market with an injectable cellular therapy that is potentially capable of actually replacing dead and dying neurons in the midbrain, while directly offsetting Parkinson’s symptoms. This solution also offers substantial protection to surviving neurons, shielding them from further deterioration. Considerable pre-clinical animal model testing has already shown extremely promising results and the progress ISCO is set to make via the Phase I/IIa clinical trial in humans could propel the company to stardom as the first to develop an actual solution for Parkinson’s sufferers.

This same technology, because it employs high purity functional adult human cells that have been created from unfertilized donor eggs at the company’s state-of-the-art Oceanside, California, facility using an ethical, patented chemical differentiation process, could also evolve into frontline treatments for other CNS (central nervous system) maladies such as Alzheimer’s and stroke. The FDA’s recent IND approval of Stemedica’s allogeneic (same species but genetically dissimilar and generally immunologically incompatible) stem-cell therapy for a Phase IIa clinical study in Alzheimer’s at UC San Diego shows how much potential there is for this kind of technology, and how receptive the FDA has become to stem cell technology.

ISCO’s ability to manufacture commercial-scale batches of both precisely human leukocyte antigen-matched (HLA) and therefore histocompatible human parthenogenetic stem cell lines, as well as HLA-homozygous lines that are suitable for significant segments of the overall population, gives the company a real edge here as well. Stemedica’s allogeneic stem cells, for instance and by contrast, are cultivated from donor tissues, not differentiated from unfertilized eggs. Thus, ISCO’s technology is quite remarkable, because it substantially overcomes one of the main challenges facing stem cell therapeutics as a viable solution to numerous diseases; namely, cell rejection by the patient’s immune system.

International Stem Cell Corporation could be first to market a treatment actually capable of halting the progression of Parkinson’s disease in its tracks, or even reversing the impact of the disease. Results from the company’s landmark human clinical trial should start to become available in the coming months and investors should keep a close eye on ISCO for breaking news.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Alternet Systems, Inc. (ALYI) Promoting Tech of the Future

Alternet Systems, Inc. (OTCQB: ALYI) is preparing people for a new age of digital living. The company, which invests in technological tools that enable and expedite commerce, is focused on elevating its customers’ – and partners’ – experience with multichannel payments, digital commerce and predictive analytics. By concentrating on improving efficiency, the company is pushing to become a leading global provider in these industries.

As an enterprise accelerator company, Alternet maintains a vigilant eye on the fast growth markets that surround newly-adapted Internet technologies and platforms, such as Internet and mobile commerce, digital currency and cyber-security products and services. Once it spies a high growth opportunity in these markets, the company and its subsidiaries pursue and aim to convert them into income streams.

One key initiative that Alternet has been pursuing and developing is a plan to offer multi-channel payment solutions, as well as Near Field Communication (NFC) point of sale solutions, electronic point of sale modernization and financial services software for the mobile finance and payment processing industry.

This past August, the company achieved a milestone in the multi-channel payment space. Alternet Payment Solutions, a subsidiary of Alternet Systems, joined forces with MUXI to provide U.S. payment processors and independent sales organizations with a flexible, maintained multi-channel point-of-sale payment processing solution. With a prospective market reach that includes over 20 million merchants in the U.S., this is a potentially disruptive offering in the nation’s omni-channel payment processing space and one that is in high demand from small- and medium-sized enterprises who appreciate the affordability of mobile point of sale terminals, as compared to fixed point of sale terminals.

For MUXI, a subsidiary of APPI Group, Alternet makes a formidable partner as it embarks on a run to expand globally. The affiliation with Alternet will enable MUXI to stretch its sales and support presence within the U.S. while relying on the Alternet management team’s century worth of experience and understanding of the payments market.

How does the MUXI technology work? The company’s solution offers customers a point of sale admin platform that gives them complete control over their network and assets, and by complete control, the MUXI means complete control. The platform runs independently of point of sale manufacturers. At the same time, it enables remote and improved application updates across all point of sale platforms. In fact, applications within the platform extend the functions of the point of sale foundation across mobile devices (e.g. smartphones and tablets).

For more information, visit www.alternetsystems.com

Let us hear your thoughts: Alternet Systems, Inc. Message Board

Avant Diagnostics, Inc. (AVDX) Leading the Next Advance in the ‘War on Cancer’ through the Development of OvaDx®

The American Cancer Society estimates that about 21,290 new cases of ovarian cancer will be diagnosed in 2015, and roughly 14,180 women will die from the illness within the United States. These figures outline the severity of ovarian cancer, which is currently the eighth most common cancer among women, as well as the fifth leading cause of cancer-related death among women, according to data from SEER. Over the past forty years, mortality rates for ovarian cancer have recorded a mild decline as a result of the ongoing ‘War on Cancer’, but these improvements pale in comparison to the progress made on some other forms of the disease. Today, nearly half of all cancer patients can expect to live for five or more years after diagnosis with proper treatment.

With this data in mind, the question regarding ovarian cancer becomes clear: Why hasn’t more progress been made toward improving survivability? To understand the answer to this question, one needs to take a closer look at the illness.

Ovarian cancer begins when healthy cells in an ovary mutate and begin to grow uncontrollably, forming a mass known as a tumor. Tumors come in two basic forms – cancerous and benign. While benign tumors can cause problems by continuing to grow, cancerous tumors are, by far, the more dangerous form. Cancerous tumors on the ovaries are malignant, meaning they can continue to grow and spread to other parts of the body. For this reason, catching the disease in its early stages is paramount to improving survivability rates.

When diagnosed early, ovarian cancer is actually an extremely survivable disease. According to data from the American Cancer Society, individuals with ovarian cancer that’s diagnosed in stage I boast a five-year survivability rate of approximately 90 percent. However, this outlook is significantly worse when the illness isn’t discovered until the later stages. In stage II, the five-year survivability rate for invasive epithelial ovarian cancer, which accounts for roughly 85 percent of all cancers of the ovaries, falls to 70 percent. In stage III, survivability is just 39 percent.

With the importance of early detection clearly illustrated, a massively underserved indication within the diagnostic market becomes evident. The National Ovarian Cancer Coalition reports that almost 70 percent of women diagnosed with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage.

Current ovarian cancer detection methods are hampered by a variety of factors. The simplest check, a pelvic exam, consists of a health care professional feeling the ovaries and uterus for size, shape and consistency. While these tests are relatively effective for some reproductive system cancers, most early ovarian tumors are difficult or impossible for even the most skilled examiner to feel. Screening tests and exams are also used for detection in people who don’t display any symptoms. However, both transvaginal ultrasound (TVUS) and the CA-125 blood test have drawbacks.

In the case of TVUS, sound waves are used to study the reproductive system. These waves can help physicians locate tumors on the ovaries, but they doesn’t help determine if the mass is cancerous or benign. The CA-125 blood test, on the other hand, checks the patient’s blood for high levels of the CA-125 protein, which is commonly associated with ovarian cancer. The effectiveness of this test is also hindered, because many common conditions other than cancer can cause high levels of CA-125.

Avant Diagnostics, Inc. (OTCQB: AVDX) is developing a novel approach to ovarian cancer screening that has the potential to fill this underserved need in the medical community. OvaDX® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. In clinical research, OvaDX has displayed high sensitivity and specificity for all types and stages of ovarian cancer – including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous and ovarian adenocarcinoma. Following FDA approval, Avant plans to market OvaDx to doctors as a supplement to existing tests for women seeking greater wellness, as well as those in the elevated risk category for ovarian cancer.

As of its latest update, Avant had received FDA approval for ovarian cancer specimens to be used in a forthcoming validation study to support a pre-submission package to the FDA. After this package is submitted and reviewed, the company will look to commence the OvaDx 510(k) trial, which it plans to conduct in a double-blinded environment supervised by an independent clinical research organization.

For more information, visit www.avantdiagnostics.com

Let us hear your thoughts: Avant Diagnostics, Inc. Message Board

Cherubim Interests (CHIT) Alternative Investment Opportunities Showing Growth Signs in Multiple Areas

Cherubim Interests, Inc. (OTC: CHIT) is an investment company with its energy and resources centered on single and multi-family dwellings for purchase. The company also targets undervalued commercial assets. Cherubim’s business model is geared toward becoming a leader in property management, alternative construction, multifamily real estate, and investment opportunities. A trademark of the company is its hands-on involvement with each project from start to finish, addressing general management, acquisitions and construction. Company initiatives promote safer living and enhanced lifestyles that drive maximized shareholder value for its investors.

In a recent adjunct move to facilitate its growth plans, Cherubim signed a Memorandum of Understanding (MOU) with United Cannabis Corp. (OTCQB: CNAB) to supply, deploy and provide the technical means to cultivate cannabis.

“This industry is moving very rapidly,” stated Patrick J. Johnson, CEO of Cherubim Interests, Inc., in a recent news release. “As we see the front of legalization push across states and even into the platforms of the next presidential election, companies are scrambling to catch up. The market is there, the demand is high, but the supply from legal cultivators is low. Cherubim Interests and BudCube are uniquely positioned at this perfect apex of an emerging, billion dollar market; we are positioning ourselves to meet the impending demand by supplying the facility necessary to bring existing as well as start-up companies into full scale production in a matter of months.”

Cherubim will own, manage and develop new properties while BudCube will oversee the technology and cannabis cultivation system application. Both companies will partner to deliver single and multi-tenant solutions for prospective cannabis growers. This strategy is expected to deliver handsome financial growth numbers for both companies.

Cherubim is led by a group of highly experienced directors and a management team with expertise in a variety of disciplines ranging from property management and construction to finance. CHIT is determined to fulfill its vision of becoming a leader in the fields of alternative construction, multi-family real estate development, property management, and investment.

For more information, visit www.cherubiminterests.com

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

Legacy Ventures International, Inc. (LGYV): Boxed Water Will Replace Bottled Water

Environmental awareness, recycling, saving the rain forests, reducing carbon emissions and lowering carbon footprints are all much needed practices for running a business in the 21st century. Contradictory to so many popular science fiction blockbusters, there is only one planet that we can call home, so it is refreshing to see more and more people and businesses implementing environmentally friendly operations into their business strategies. Legacy Ventures International, Inc. (OTCQB: LGYV) spearheads this effort with its Boxed Water product.

Since ‘Being Green’ is in and a recent climate agreement in Paris was reached, Legacy Ventures is in a prime position for growth with its Boxed Water product. Boxed Water provides an alternative sustainable package for water consumption, as it is packaged in a 100 percent recyclable carton and not a plastic bottle. In shipping alone, Boxed Water significantly lowers the carbon footprint of traditional portable water solutions. One truckload of Boxed Water cartons is equivalent to twenty-six truckloads of plastic bottles. Boxed Water supports world water relief, reforestation, and environmental protection projects.

Political changes like the agreements reached at the 2015 United Nations Climate Change Conference in Paris are springboards for companies to alter and change the way they do business in order to comply with upcoming requirements and legislation. Legacy Ventures had the foresight to position itself to capitalize on this evolving landscape with a game-changing product like Boxed Water.

‘Waste not, want not’ should be one of the slogans for Boxed Water. Making bottles to meet America’s demand for bottled water uses more than seventeen million barrels of oil annually, enough to fuel 1.3 million cars for a year. Americans used about fifty billion plastic water bottles last year. However, the U.S.’s rate for recycling plastic is only 23 percent, which means 38 billion water bottles – more than $1 billion worth of plastic – are wasted each year, according to a ban the bottle website.

Boxed Water is the future, and Legacy Ventures is positioned for serious growth, especially, considering recent developments around the globe.

For more information, visit www.legacyventuresinc.com

Let us hear your thoughts: Legacy Ventures International, Inc. Message Board

Content Checked Holdings (CNCK): User Specific Grocery Shopping with Your Smartphone

Healthy grocery shopping can be hard enough when it’s just for you. Now imagine the headaches that accompany shopping for your entire family, while avoiding potentially dangerous foods due to your family members’ allergies and dietary requirements. Luckily, a cutting-edge company, Content Checked Holdings, Inc. (OTCQB: CNCK), has done all the research for you and created a suite of easy-to-use apps readily available to download on your smartphone or tablet.

ContentChecked is an app that will help users make better food choices for their food allergy and intolerance needs. When in the grocery store, users can scan a product barcode on a food or beverage product. The app will then tell the user whether or not that product is suitable for them based on their allergy settings and will provide the user with similar alternatives if the product does contain one or more of their allergens. Educating consumers about food ingredients and helping them avoid trips to the emergency room are two of the company’s goals when developing apps.

The company began with a simple idea: to ease the frustration of a father trying to grocery shop for his daughter and her friends while taking into consideration their countless food allergies and intolerances. Transforming the trudging task of picking out groceries into a fun, interactive and educational scavenger hunt is the ultimate goal of Content Checked Holdings.

In today’s health conscience world where consumers test diet after diet, it is refreshing to find a company like Content Checked whose mission is to educate the consumers on products readily available in most local grocery stores throughout the U.S. Once we inculcate ourselves on what foods are bad for our diet and which alternatives we should put in the shopping cart instead, our lives will become much healthier and food will become more fulfilling.

For more information, please visit the company’s website at www.ContentChecked.com.

Dominovas Energy Corporation (DNRG) Surges Forward with Clean Electricity Solution to Power the World

In a world where alternative energy trends are increasingly becoming essential, Dominovas Energy Corporation (OTCQB: DNRG) seeks to lead the way with its clean electricity technology. The company focuses its innovative endeavors on providing green electricity to areas all over the world while promising low-costs and high-output.

Dominovas Energy uses solid oxide fuel cell (SOFC) technology as the core of its proprietary RUBICON™ system. SOFCs have a minimal environmental impact because they generate electricity without harmful emissions while keeping production costs down.

Using this technology, RUBICON™ converts practically any hydrocarbon fuel into usable, clean electricity, resulting in a more efficient, and environmentally friendly operational system, when compared to standard power productions. This innovative fuel cell system emits heat when generated and allows any excess to be used for heating water, producing steam, supporting cooling systems, and any other additional energy uses. All the while, the RUBICON™ produces less greenhouse gas pollutants, which can damage the environment.

Dominovas Energy can also place its power generating fuel cell systems in immediate proximity to the end user to ensure lower operational costs by avoiding costly infrastructure, transmission line maintenance, vandalism and sabotage, and unrecoverable transmission degradation and other typical challenges. The company has also built-in the ability to remotely monitor its system and promises 100% reliability of the energy produced. The company will have the capability to identify and correct systems errors long before clients realize there is any complication, and, because the systems are modular, the entire megawatt complex does not have to be shut down, which means the client never loses power. This monitoring system uses a customized 5G wireless transmission that trumps the average 3G and 4G speeds.

Led by scientist and engineer, Dr. Shamiul Islam, the company says its RUBICON™ fuel system technology is “quickly becoming the ‘Platinum Standard’ by which all other fuel technologies are measured.”

Dominovas Energy believes in creating alternative green energy solutions that are cost effective and highly efficient. The company’s proprietary RUBICON™ system exemplifies these goals by demonstrating its value as a superior-grade product that keeps clients confident that their green energy is of the highest quality.

For more information, visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

Latitude 360 (LATX) Mega Venue Model Winning Over Consumers with Luxury Dine-In Movies, Live Entertainment, Fantasy Sports Betting

There are more choices available today than ever before for consumers who want to enjoy a night out, either with their friends and colleagues or their families. One might even say there are too many options competing for consumer’s entertainment dollar, making the very task of selecting a venue something that routinely becomes an open debate, as a given party’s tastes and interests all jockey for position. Hence a continuing trend within the industry toward consolidating more options into a single location.

One of the segments of the market where this is especially clear is at the box office, which saw slight declines in ticket sales last year to around $10.4 billion in North America and $36.4 billion worldwide, according to the MPAA, as pressure from streaming sources like Netflix (NASDAQ: NFLX) and Amazon (NASDAQ: AMZN) Video continue to mount. This trend has meant big business for innovative private companies like Alamo Drafthouse Cinemas, one of the first movers when it comes to dine-in theaters combining more comfortable seating with casual dining and alcoholic beverage choices in order to win over increasingly difficult to court movie goers.

The sector’s largest players, such as AMC Entertainment Holdings (NYSE: AMC), are also gravitating more and more in this direction, with an increasingly prominent bottom line component that consists of dine-in theaters. This move has been tracked closely and emulated by other motion picture exhibitors such as Regal Entertainment Group (NYSE: RGC) and more globally-focused players like Cinemark (NYSE: CNK), which recently opened a new 14-screen theatre in Roanoke, Texas, based on its NextGen cinema design concept, featuring luxury recliners and a larger menu, including a full selection of alcoholic beverages. A recent survey by RBC indicates that nearly half of all respondents do not have a favorite theater chain, but the overwhelming majority did express a desire to patronize locations that featured upgraded seating and concession options, as well as those venues which offered alternative content. To wit, 24 percent of respondents in the RBC survey cited AMC by name, likely due to its continuing emphasis on improving the overall customer experience by offering precisely such expanded offerings.

But why stop at dinner and a movie? Still quite rare, but increasingly prominent up-and-comers such as award-winning pioneer Latitude 360 (OTC: LATX) have already jumped ahead a page. Latitude 360 fuses together just about every option consumers have to choose from into a winning package that elegantly combines diverse entertainment options under a single roof. Sure, consumers can enjoy an exceptional meal and drinks off of a giant menu, alongside a Hollywood blockbuster displayed on a 25 by 11 foot screen backed up by over 10,000 watts of thumping DTS™ digital surround sound at a luxurious, yet intimate, dine-in Cinegrille® cinema at one of Latitude 360’s growing footprint of 35,000 to 85,000 square foot locations – but they can also take in the numerous other entertainment options as well. Options ranging from a full sports bar with HD screens and a separate sports theatre, to Las Vegas-style live entertainment such as music and comedy, as well as dancing, premium bowling, a game arcade, and even a luxury cigar lounge.

This mega fusion of entertainment venue options, which the company touts as the “360 Experience,” takes brilliant advantage of economies of scale, while also offering consumers the most compelling entertainment one-stop-shop available anywhere. No longer must families or coworkers argue over where to go for lunch, or for dinner and a movie, so long as there is a Latitude 360 in their town. The company has even been breaking new ground in terms of the options available, with recent additions such as a cutting edge real money fantasy sports gaming platform called 360 Fantasy Live, which gives guests the ability to participate in daily contests while watching the game on massive HD screens in comfort. This one option is a huge advantage for LATX, given that there are now nearly 52 million players in North America alone, according to 2015 data from the Fantasy Sports Trade Association, and daily fantasy sports games will generate some $2.6 billion in entry fees this year, with the market growing at a rate of 41 percent per annum through 2020 to over $14.4 billion (Eilers Research).

Tack on how LATX has recently embraced an on-premise integration of a branded ordering and payment app via partnership with mobile payments solution provider MyCheck, and it becomes readily apparent how this incredibly investor-accessible company with five locations throughout the U.S. is laser-focused on maximizing the customer experience. Set to debut in the coming months, the branded app will not only revolutionize the customer experience by allowing guests to easily order/reorder from the menu, it will also allow them to review and split the bill amongst friends from their smartphone(s), subsequently giving them access to such emerging payment methods as Apple’s (NASDAQ: AAPL) Apple Pay – the app will also provide LATX’s business model with overhead shearing benefits.

Latitude 360 is clearly ahead of the curve when it comes to the entertainment venue market, fully answering questions that many consumers have not yet even begun to ask, but one of the driving reasons behind the success of the company’s upscale multi-dimensional entertainment eateries is an overarching commitment to top shelf customer service. The company’s highly trained and attentive staff will have their jobs made easier by the addition of the new branded app, opening doors to enhanced service capabilities in other areas, likely leading to an even stronger rapport with local markets, such as those surrounding existing Latitude 360 locations in Jacksonville, Pittsburgh and Indianapolis, as well as its newly acquired locations in Syracuse, and Bethlehem, PA. The company has also signed a deal with established restaurant and hospitality group, Al Sedriyah, opening up the Latitude 360 brand for franchise locations in Qatar and Saudi Arabia, showing that this business model not only has universal appeal, but that management has no intentions of slowing down.

For more information on the company visit www.latitude360.com

Let us hear your thoughts: Latitude 360, Inc. Message Board

From Our Blog

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’

May 7, 2025

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings such as opiates, cocaine, methamphetamine, and cannabis. This innovative […]

Rotate your device 90° to view site.